Delivery Order SPE2DR25D1053-SPE2DR26FT656
- Not listed
- The Defense Logistics Agency awarded a $9,266.70 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Tavalisse 100 mg on August 5, 2025, with completion targeted for August 26, 2025. This competitively awarded, firm fixed price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $9,266.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of Tavalisse 100 mg tablets (60-count units). This is a non-set-aside contract with a completion date of July 31, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Tavalisse 100 mg tablets (60-count units) with a contract ceiling value of $9,266.70. This firm fixed-price delivery order, which is not set-aside and competitively awarded, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Tavalisse 100 mg tablets (60-count units) under a firm fixed-price contract valued at $9,266.70. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of October 16, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania, where the company is headquartered. This delivery...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $9,296.97 to AmerisourceBergen Drug Corp for the supply of Tavalisse 150 mg tablets (60-count) on August 15, 2025, with a completion date of September 8, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Tavalisse 100 mg tablets (60-count units) with a ceiling value of $18,533.40. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 10, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competed among all eligible...
- The Defense Logistics Agency awarded a $9,296.97 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Tavalisse 150 mg, a pharmaceutical product delivered to the company's corporate office location in Conshohocken, Pennsylvania. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Tavalisse 100 mg tablets in quantities of 60 units. This is a firm fixed-price delivery order with a ceiling value of $18,533.40 and an ultimate completion date of August 12, 2025. The award represents a non-competitive, non-set-aside delivery order issued under AmerisourceBergen's existing contract vehicle with DLA. Tavalisse is a pharmaceutical product used in the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Tavalisse 100 mg tablets (60-count units) with a ceiling value of $9,266.70. This firm fixed-price delivery order, due for completion by September 23, 2025, represents a non-set-aside competitive award to support federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain on September 5, 2025, for the supply of Tavalisse 100 mg tablets (60-count) with a contract ceiling value of $18,533.40. The contract is structured as a firm fixed price delivery order with an ultimate completion date of September 26, 2025, and carries no set-aside designation, indicating it was competitively awarded. Performance will be executed from the awardee's corporate office...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FT656Delivery Order
The Defense Logistics Agency awarded a Delivery Order contract valued at $9,797.57 to AmerisourceBergen Drug Corp for the supply of Tavalisse 150 mg tablets (60-count units). This non-competitive, firm fixed-price delivery order was issued on November 5, 2025, with an ultimate completion date of November 28, 2025. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999 and runs through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's supply chain. The company maintains an extensive portfolio of pharmaceutical products and medical supplies across multiple therapeutic domains. As the prime vendor under the DLA Troop Support Medical IDC, AmerisourceBergen fulfills delivery orders for brand-name and generic medications, vaccines, and specialized medical supplies that support Defense Health Agency, U.S. Coast Guard, and other government healthcare programs globally. This specific delivery order for Tavalisse, a specialty pharmaceutical treatment, exemplifies the company's role in providing targeted medications to federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.8k | 11/5/25 |